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Abstract
BACKGROUND: Clinician-rated large-scale studies estimating the prevalence of posttraumatic stress
disorder (PTSD) related to myocardial infarction (MI) and identifying predictors of clinical PTSD are
currently lacking. HYPOTHESES: We hypothesized that PTSD is prevalent in post-MI patients and that
the subjective experience of the MI determines PTSD status. METHODS: We approached 951 post-MI
patients with a questionnaire screening for PTSD symptoms related to their MI. Those responding and
meeting a cutoff of PTSD symptom levels were invited to participate in a structured clinical interview to
diagnose PTSD following Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria.
Fear of dying, feelings of helplessness, and severity of pain perceived during the MI were also assessed
by visual analog scales. RESULTS: The screening questionnaire was completed by 394 patients,
whereby 77 met the cutoff for the interview (8 patients declined the interview). Forty of 394 patients
(10.2%) had clinical PTSD (subsyndromal and syndromal forms combined). Younger age (OR 0.95,
95% CI 0.91-0.99), greater fear of dying (OR 2.77, 95% CI 1.28-5.97), and more intense feelings of
helplessness (OR 2.97, 95% CI 1.42-6.21) were independent predictors of PTSD status. Perceived pain
intensity during MI, sex, type of index MI, left ventricular ejection fraction, number of coronary
occlusions, and highest level of total creatinine kinase were not significant predictors. CONCLUSIONS:
Clinical PTSD is prevalent in post-MI patients. Demographic and particularly psychological variables
related to the subjective experience of the event were stronger predictors of PTSD status than were
objective measures of MI severity.
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CONDENSED ABSTRACT 
Myocardial infarction (MI) can be viewed as a traumatic event. Performing a 
structured interview, we found that 10% of 394 post-MI patients had a clinical form (i.e. 
subsyndromal or syndromal forms combined) of posttraumatic stress disorder (PTSD) related 
to their MI. Younger age, as well as greater fear of dying and helplessness experienced during 
the MI were independent predictors of clinical PTSD. The prevalence of clinical PTSD is 
considerably high in post-MI patients. Subjective perception of the MI may predict the 
development of PTSD in the aftermath of MI. 
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SUMMARY 
Background: Clinician-rated large-scale studies estimating the prevalence of 
posttraumatic stress disorder (PTSD) related to myocardial infarction (MI) and identifying 
predictors of clinical PTSD are currently lacking. 
Hypotheses: We hypothesized that PTSD is prevalent in post-MI patients and that 
subjective experience of the MI determines PTSD status. 
Methods: We approached 951 post-MI patients with a questionnaire screening for 
PTSD symptoms related to their MI. Those responding and meeting a cut-off of PTSD 
symptom levels were invited to participate in a structured clinical interview to diagnose PTSD 
following Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria. Fear of 
dying, feelings of helplessness, and severity of pain perceived during the MI were also 
assessed by means of visual analogue scales. 
Results: The screening questionnaire was completed by 394 patients, whereby 77 met 
the cut-off for the interview (8 patients declined the interview). Forty patients (10.2% of 394) 
had clinical PTSD (subsyndromal and syndromal forms combined). Younger age (OR 0.95, 
95% CI 0.91-0.99), greater fear of dying (OR 2.77, 95% CI 1.28-5.97), and more intense 
feelings of helplessness (OR 2.97 95% CI 1.42-6.21) were independent predictors of PTSD 
status. Perceived pain intensity during MI, gender, type of index MI, left ventricular ejection 
fraction, number of coronary occlusions, and highest level of total creatinine kinase were not 
significant predictors. 
Conclusions: Clinical PTSD is prevalent in post-MI patients. Demographic and 
particularly psychological variables related to the subjective experience of the event were 
stronger predictors of PTSD status than objective measures of MI severity. 
 
Key words: Cardiovascular disease; myocardial infarction, posttraumatic stress disorder 
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INTRODUCTION 
Clinicians are aware that patients may experience a myocardial infarction (MI) as a 
traumatic event1 that commonly provokes intense emotions and challenges normal daily 
functioning.2,3 Approximately 15% of patients develop posttraumatic stress disorder (PTSD) 
in the aftermath and related to their MI.1,4 Although a psychiatric disorder, PTSD is 
increasingly acknowledged as an important clinical entity in cardiovascular medicine.5 PTSD 
is associated with poor compliance with cardiac therapy6 and cardiovascular outcome.7 To 
meet the definition for PTSD,8 patients must have experienced the MI as an event involving 
threatened death to which they responded with intense fear or helplessness. Patients must also 
have reexperienced the MI e.g. in thoughts or dreams, avoided stimuli associated with the MI, 
and had symptoms of heightened arousal for at least one month. 
Previous investigations largely applied self-rated symptom questionnaires, which tend 
to overestimate the prevalence of PTSD in post-MI populations.1 Clinical interviews yielded 
prevalence rates between 0 and 8%, although in comparably small samples.9-11 Using a 
structured clinical interview, we recently diagnosed 9.4% of 190 patients with DSM-IV PTSD 
related to their MI.12 Owing to its limited sample size, that study did not allow us to reliably 
probe for predictors of a clinical PTSD diagnosis.  
Therefore, we continued enrolment of post-MI patients in our previously described 
protocol,12 thereby roughly doubling the sample size. We predicted a prevalence of clinical 
PTSD of about 10%. We hypothesized that subjective experience of the MI determines PTSD 
status at least as strongly as do demographic variables and objective measures of MI severity. 
 
METHODS 
Study design and participants  
The Ethics Committee of the State of Bern, Switzerland, approved the study protocol 
in accordance with the Declaration of Helsinki. All patients provided informed consent. We 
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approached 951 patients by mail who had previously been referred to the Cardiology 
Department of the Bern University Hospital, Switzerland, with a verified STEMI or NSTEMI 
as per previously published guidelines. 12,13. All included patients had undergone percutaneous 
transluminal coronary angioplasty at admission. Patients were excluded if they did not speak 
German or lived too far away from the University Hospital (>90 minutes by car or train). 
 
Psychometric assessment 
Screening for PTSD symptom levels: We mailed the self-rated Posttraumatic 
Diagnostic Scale (PDS)14 to all 951 patients with a verified MI. We applied the validated 
German version of the PDS showing excellent internal consistency (Cronbach’s α = .91) 
(Steil, unpublished manuscript).15 The PDS comprises 17 questions mapping onto DSM-IV 
symptoms for PTSD, yielding a maximum score of 51 points. Patients who met the cut-off of 
≥15 points16 were invited for the structured interview. 
Subjective experience of infarction: Patients retrospectively rated three aspects of MI 
perception on Likert scales: a) fear of dying: “During my referral to the hospital, the 
emergency unit, or the intensive care unit, I was afraid I was dying.” (0 = absolutely not true, 
10 = absolutely true); b) helplessness: “When the doctor told me I had a heart attack, I was 
frightened, felt helpless, and was afraid of losing control of the situation.” (0 = absolutely not 
true, 10 = absolutely true); c) pain intensity: “Please indicate how strong your pain was during 
the heart attack.” (0 = no pain at all, 10 = intolerable pain). 
Diagnosis of clinical PTSD: We used the Clinician-Administered PTSD Scale 
(CAPS) for the structured interview as developed by the National Center for PTSD to 
diagnose DSM-IV PTSD.17 The German version shows good internal consistency for the 
severity score of all 17 symptom items (Cronbach’s α =.88-.92) and for each of the three (i.e. 
B, C, D; cf. below) PTSD symptom clusters (α =.73-.88).18 The frequency and intensity of 
each symptom is rated between 0 (never) and 4 (almost always). A symptom is given when 
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frequency ≥1 point and intensity ≥2 points. One of 5 symptoms are required for criterion B 
(re-experiencing cluster), 3 of 7 symptoms for criterion C (avoidance cluster), and 2 of 5 
symptoms for criterion D (hyperarousal cluster). PTSD severity is obtained by adding up 
symptom scores of criteria B+C+D. Patients were diagnosed with syndromal PTSD if meeting 
criteria B+C+D and with subsyndromal PTSD if meeting criterion B plus either C or D.19
 
Demographic and medical data 
Age, gender, date of index MI, type of index MI (first-time vs. recurrent MI), left 
ventricular ejection fraction (LVEF) as measured by ventriculography during coronary 
angiography, the number of coronary occlusions, and highest levels of total serum creatinine 
kinase (CK) were obtained from medical charts. We used the number of coronary occlusions 
LVEF, and total CK as proxy measures of objective MI severity. Total CK levels and their 
time courses during the acute phase of the MI were measured by different laboratories and did 
not follow a standardized protocol; therefore, “highest” CK levels do not necessarily reflect 
“peak” levels at 24 h after MI onset. Accordingly, the highest CK levels could be close to 
normal values in subjects who only had CK measured in the first couple of hours post-MI. 
 
Statistical analyses 
We used SPSS 13.0 statistical software package (SPSS Inc. Chicago, IL) setting 
significance levels at p<.05 (two-tailed). Data for PDS and Likert scores, number of days after 
MI the PDS was sent out, LVEF, and CK levels were not normally distributed (Kolmogorov-
Smirnov Test) and transformed by the Blom procedure before analyses. For clarity, we 
present all data in original units (means±SD, range). Calculations of differences between 
groups used Student’s t-test, Pearson chi-square test, and Fisher’s exact test. We applied 
logistic linear regression analysis (Wald test) to identify OR (95% CI) of predictors of clinical 
PTSD diagnosis and Nagelkerke R2 statistics to estimate effect sizes. 
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RESULTS 
Patient characteristics 
Of the 951 patients approached, 426 returned the PDS questionnaire (accrual rate 
45%). Of these, 16 declined to participate and another 16 had died, whereby their relatives 
had sent back the questionnaire leaving 394 patients whose characteristics are presented in 
Table 1. Data were missing for CK levels in 54 patients, for LVEF in 13 patients, for fear of 
dying in 9 patients, and for feelings of helplessness and perceived pain in 6 patients each. The 
type of the index event was unclear in 7 patients and coded as first-time MI. Eight patients 
and four patients, respectively, missed one and two items of the PDS questionnaire; these 
were replaced with the mean of completed items. The 394 patients who responded to the 
survey did not differ in age from the 525 patients who did not respond (p=0.86). The 
proportion of non-responders was higher in women (67%) than in men (55%) (p=0.002). 
 
Clinical diagnosis of PTSD 
Seventy-seven (19.5%) patients met the PDS cut-off score for the diagnostic 
interview. Eight patients declined the interview (5 men, 3 women; PDS score 21±7, range 15-
34). Of the 69 patients interviewed, 14 had syndromal PTSD (20%), 26 had subsyndromal 
PTSD (38%), and 29 (42%) did not fulfil the criteria for clinical PTSD. With regard to the 
entire sample of patients screened (n=394), the prevalence of a clinical diagnosis of PTSD 
(either syndromal or subsyndromal) was 10.2%. Table 2 demonstrates that relative to patients 
without PTSD, those with PTSD were younger and, expectedly, scored higher in 
posttraumatic stress levels (questionnaire and interview), in fear of dying, and in helplessness.  
 
Predictors of clinical PTSD 
To identify independent demographic, medical, and psychological predictors of 
clinical PTSD (subsyndromal and syndromal forms combined), we computed logistic 
 7
regression analysis on the entire sample of 394 patients. The eight patients who declined to 
undergo the CAPS interview were grouped along with the 346 patients who did not have 
PTSD as per a PDS score <15 points (n=317) or following the CAPS interview (n=29).  
Table 3 shows the results of the regression model we built by subsequently entering 
three blocks of independent variables. Younger age (B= – 0.05 ± 0.02, p=0.023), greater fear 
of dying (B=1.02 ± 0.39, p=0.009), and more intense feelings of helplessness (B= 1.09±0.38, 
p=0.004) emerged as independent predictors of PTSD status, whereas gender, type of index 
event, LVEF, number of coronary occlusions, time since the PDS questionnaire was sent out, 
and perceived pain were not. 
We computed two complementary analyses. The first one omitted the eight subjects 
who declined to be interviewed; younger age (p=0.022), greater fear of dying (p=0.013), and 
more helplessness (p=0.003) were all maintained as significant predictors of PTSD status. The 
second analysis also considered CK levels and was performed on 34 patients with PTSD and 
306 without. Again, younger age (p=0.017), greater fear of dying (p=0.036), and more 
helplessness (p=0.011) were maintained as significant predictors of PTSD status; LVEF 
(p=0.50), the number of coronary occlusions (p=0.28), and CK levels (p=0.68) were not 
significant predictors. 
 
DISCUSSION 
While we recently diagnosed 9.4% of patients with DSM-IV PTSD in the first 190 
post-MI patients screened and enrolled in the current protocol,12 this prevalence was largely 
maintained when doubling the sample. This finding speaks for the robustness of the 
observation that about 10% of patients develop PTSD in the aftermath of an acute MI. 
Together with prevalences of 7%10 and 8%,11 respectively, found in smaller studies also 
applying an interview, our data suggest that clinical PTSD is not a negligible disorder in post-
MI patients. To compare, 12-month prevalence of subsyndromal PTSD was less than 2% and 
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no individual met criteria for syndromal PTSD in a representative Swiss population sample.20 
These interview data also support our previous notion that self-rated PTSD symptom 
questionnaires may yield too high prevalence rates (i.e. approximately 15%).1 
In the patients who underwent the clinical interview, those with clinical PTSD were 
younger and had also felt relatively greater fear of dying and helplessness during the MI 
relative to those without PTSD. Interestingly, the trend towards a relatively longer period 
since the MI in patients with PTSD might suggest that once established, clinical PTSD may 
not readily wane over time.  
In the entire sample, younger age and greater levels of fear of dying and helplessness 
perceived during the MI emerged as independent predictors of clinical PTSD, whereas 
gender, type of MI, LVEF, the number of coronary occlusions, and highest CK levels did not. 
These findings are in line with previous studies showing that younger age, and perceived 
threat, but not gender, CK levels, index event and other objective measures of MI severity, 
were associated with PTSD symptom levels.21-23 We did not find that perceived pain predicted 
PTSD status contrasting with previous studies in which pain scores did predict self-rated 
PTSD symptom levels.12,22 We interpret that our study provides little evidence for the 
assumption that certain demographic, medical, and psychological factors differentiate clinical 
PTSD status from elevated PTSD symptom levels. This might be expected since post-
traumatic stress occurs on a continuum of severity.23
The application of a structured clinical interview and the ample sample allowing us to 
identify predictors of clinical PTSD status were strengths of our study, which, however, also 
had its limitations. More than half of the patients approached and particularly women did not 
respond to the survey. Therefore, our findings are not necessarily transferable to a general 
post-MI population. Nevertheless, the accrual rate was comparable to similar studies.21-23 It 
could be that posttraumatic stress levels were comparably higher in patients who declined to 
participate to avoid being reminded of the MI in an interview.21 If so, the “true” prevalence of 
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clinical PTSD might be even higher in a general post-MI population. CK measurements were 
not standardized and the retrospective assessment of MI perception could have inflated a 
recall bias. Particularly, the time between the MI and assessment of its subjective perception 
was considerably heterogeneous ranging between two weeks and almost five years. The 
subjective perception of the MI at admission will decrease as time goes by. Finally, we did 
not assess other potentially important predictors of PTSD status such as previous psychiatric 
disorders and social support.4 
Altogether, we found that PTSD is a clinical disorder with a considerably high 
prevalence in post-MI populations. Psychological variables related to the subjective 
experience of MI predicted PTSD status better than did objective measures of MI severity. 
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Table 1. Characteristics of patients screened for PTSD (n=394) 
  
Men / Women [%] 326 (83%) / 68 (17%) 
Age [years] 61 ± 10 (38–85) 
First-time / recurrent MI [%] 362 (92%) / 32 (8%) 
Number of coronary occlusions: 1, 2, 3 174 (44%), 120 (31%), 100 (25%)  
LVEF [%] 50 ± 11 (20–75) 
Highest serum total CK level obtained [U/L] 1243 ± 1279 (8–6339) 
Sending out of PDS questionnaire after MI [days] 98 ± 157 (12–1673) 
PDS score 8.8 ± 8.9 (0–48) 
Fear of dying score 2.7 ± 3.1 (0–10) 
Feelings of helplessness score 2.9 ± 3.2 (0–10) 
Perceived pain score 6.0 ± 2.9 (0–10) 
 
Data are given as means ± SD (range) 
CK, creatinine kinase; LVEF, left ventricular ejection fraction; MI, myocardial infarction; 
PDS, posttraumatic diagnostic scale 
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Table 2. Characteristics of interviewed patients with and without PTSD (n=69) 
    
Variable Patients with PTSD 
(n=40) 
Patients without PTSD 
(n=29) 
P-value 
Men / Women [%] 31 (78%) / 9 (22%) 21 (72%) / 8 (28%) 0.628 
Age [years] 54 ± 8 (39–72) 60 ± 10 (43–79) 0.008 
First-time / recurrent MI [%] 38 (95%) / 2 (5%) 24 (83%) / 5 (17%) 0.122 
Number of coronary 
occlusions: 1, 2, 3 
23 (57%), 11 (28%), 6 
(15%) 
14 (48%), 8 (28%), 7 
(24%) 
0.603 
LVEF [%] 52 ± 10 (25–65) 54 ± 9 (25–65) 0.191 
Highest total CK [U/L] 1437 ± 1499 (78–6339) 907 ± 1011 (78–3735) 0.541 
CAPS score 52 ± 21 (20-119) 25 ± 10 (9–47) <0.001 
Days since index event 136 ± 106 (45-475) 96 ± 52 (24–224) 0.069 
PDS scale score 27 ± 9 (15-48) 19 ± 4 (15–33) <0.001 
Fear of dying score 6.7 ± 3.0 (0-10) 4.5 ± 2.9 (0–10) 0.010 
Feelings of helplessness score 7.2 ± 2.9 (3-10) 4.8 ± 3.0 (1–10) 0.004 
Perceived pain score 7.4 ± 2.6 (0-10) 7.3 ± 2.6 (0–10) 0.741 
 
Data are given as means ± SD (range) 
 
CAPS, clinician-administered PTSD scale; CK, creatinine kinase; LVEF, left ventricular 
ejection fraction; MI, myocardial infarction; PDS, posttraumatic diagnostic scale 
 
Data were missing for LVEF in 1 patient, for CK in 6 patients, for fear of dying score in 2 
patients, and for perceived pain score in 1 patient. 
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Table 3. Logistic regression analysis for clinical PTSD status  
   
Steps of the model Blocks of entered variables OR (95% CI) 
   
Step 1: forced entry a) Gender 0.60 (0.26 –1.38) 
(n=394; 40 with PTSD)  Age 0.93 (0.90 – 0.96) 
   
Step 2: forced entry b) Gender 0.67 (0.29 – 1.54) 
(n=381; 40 with PTSD) Age 0.93 (0.90 – 0.96) 
 Index event 1.31 (0.29 – 6.02) 
 LVEF 1.20 (0.82 – 1.76) 
 Number of coronary occlusions 0.76 (0.48 – 1.21) 
   
Step 3: forced entry c) Gender 0.53 (0.20 – 1.43) 
(n=375; 38 with PTSD) Age 0.95 (0.91 – 0.99) 
 Index event 2.50 (0.41 – 15.06) 
 LVEF 1.18 (0.76 – 1.85) 
 Number of coronary occlusions 0.69 (0.41 – 1.17) 
 Days since MI the PDS was sent out 1.29 (0.86 – 1.94) 
 Fear of dying 2.77 (1.28 – 5.97) 
 Helplessness 2.97 (1.42 – 6.21) 
 Pain 0.77 (0.45 – 1.32) 
 
LVEF, left ventricular ejection fraction; MI, myocardial infarction; PDS, posttraumatic 
diagnostic scale; PTSD, posttraumatic stress disorder 
a) Model accounted for 10.3% of the variance (chi-square = 20.0, df = 2, p<0.001) 
b) Model accounted for 12.0% of the variance (chi-square = 23.0, df = 5, p<0.001) 
c) Model accounted for 41.7% of the variance (chi-square = 84.1, df = 9, p<0.001) 
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